Product logins

Find logins to all Clarivate products below.


The practice known as "academic detailing," which aims to provide physicians with a more complete, evidence-based, and presumably unbiased education about what specific drugs will do, has spread rapidly in New England. Maine's Medicaid program, in an attempt to implement tighter controls and cut down on non-adherence and waste of prescriptions medications, has implemented a new policy limiting initial prescriptions to 15-day supplies on certain medications. Rhode Island's Medicaid program could see its generics first policy expand to a new subset of beneficiaries as the state re-bids its managed care contracts. Massachusetts, which implemented a near-universal reform initiative in 2006, is at a crossroads as costs are threatening the program's affordability.

Related Market Access Reports

Report
Baystate Health, Massachusetts | State IDN Profile
IDN Profiles are part of Healthbase, which is an innovative platform that helps multi-disciplinary market access teams navigate the complex healthcare ecosystem with the affiliations data and insights
Report
Main Street Health | Power Profile
Market Overview analyzes 87 metro area healthcare market dynamics, including top providers and payers. Market Overview includes MO Advanced Dashboard for segmenting and comparing markets. In 2023,
Report
BlueCross BlueShield Rhode Island | Rhode Island | 2026 | Health Plan Profile
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence
Report
Vermont | 2026 | Health Plan Analysis
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence
Report
New Hampshire | 2026 | Health Plan Analysis
Health Plan Analysis reports feature a comprehensive look at the managed care market within each state, plus the District of Columbia and Puerto Rico. The product assesses payer/provider influence